ECL-cell Hyperplasia
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
TM
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Trio Medicinesnetazepide
Clinical Trials (1)
Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin
Start: Nov 2009Est. completion: Sep 2010
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space